iBio, Inc. (IBIO)
1.93
+0.22
(+12.87%)
USD |
NASDAQ |
Dec 31, 16:00
1.90
-0.03
(-1.55%)
After-Hours: 20:00
iBio EPS Diluted (Quarterly): -0.108 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Minerva Neurosciences, Inc. | -0.3625 |
| Bionano Genomics, Inc. | -1.593 |
| Vor Biopharma, Inc. | -121.63 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
| Senti Biosciences, Inc. | -0.6911 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.72M |
| Revenue (Quarterly) | 0.10M |
| Total Expenses (Quarterly) | 5.82M |
| Enterprise Value | -2.872M |
| Gross Profit Margin (Quarterly) | -189.0% |
| Profit Margin (Quarterly) | -5.72K% |
| Earnings Yield | -72.19% |
| Normalized Earnings Yield | -72.19 |